Which of the following statements about classifying a promising drug is false?
a. the drug won't be used to treat a serious life-threatening disease.
b. there's no comparable alternative drug to treat the disease.
c. the sponsor is actively pursuing marketing approval for the drug.
d. under an ind, the drug is currently being investigated in a controlled clinical trial.
